JP4772884B2 - 血糖値の上昇を抑制するための医薬組成物及び血糖値の上昇を抑制するための薬の製造のためのポリペプチドの使用 - Google Patents
血糖値の上昇を抑制するための医薬組成物及び血糖値の上昇を抑制するための薬の製造のためのポリペプチドの使用 Download PDFInfo
- Publication number
- JP4772884B2 JP4772884B2 JP2009062569A JP2009062569A JP4772884B2 JP 4772884 B2 JP4772884 B2 JP 4772884B2 JP 2009062569 A JP2009062569 A JP 2009062569A JP 2009062569 A JP2009062569 A JP 2009062569A JP 4772884 B2 JP4772884 B2 JP 4772884B2
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- blood glucose
- glucose level
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Description
《関連する出願への相互参照》
本出願は、2008年12月01日付で出願した台湾特許出願第097146586号の優先権を主張する特許出願である。
本発明の更に別の目的は、血糖値を調整する薬の製造のための本発明のポリペプチドの使用を提供することである。
また、本発明は、本発明のポリペプチドをコードする単離ポリヌクレオチドを提供する。
本発明の詳細な技術と好適な実施形態を、当業者が本発明の特徴を良く理解できるよう下記に説明する。
次の材料が実施例において使用された。
(A)実験対象:2タイプのマウス、即ち、BALB/c(血糖の代謝は正常)とob/ob(自然糖尿病タイプ2)を実験に使用した。これらは台湾国立研究所動物センター(National Laboratory Animal Center, Taiwan)によって提供された。
(B)ポリペプチド:表1に示すアミノ酸配列を持つポリペプチドを固相合成法によって製造した。
Claims (3)
- 配列番号:1、配列番号:2、配列番号:3、配列番号:4、配列番号:5、配列番号:6、配列番号:7、配列番号:8、配列番号:9、配列番号:10、配列番号:11、配列番号:12からなる群から選択された少なくとも1つのアミノ酸配列からなるポリペプチドと、医薬的に許容される担体とを含む血糖値の上昇を抑制するための医薬組成物。
- 錠剤、カプセル、顆粒、粉末、抽出液、溶液、シロップ、懸濁液、乳濁液、チンキ剤、注射剤、静脈注射剤、粉末注射剤、懸濁注射剤、粉末懸濁注射剤、及びこれらの組合せからなるグループから選択された投与形態を有する請求項1に記載の医薬組成物。
- 血糖値の上昇を抑制する薬の製造のための、配列番号:1、配列番号:2、配列番号:3、配列番号:4、配列番号:5、配列番号:6、配列番号:7、配列番号:8、配列番号:9、配列番号:10、配列番号:11、配列番号:12からなる群から選択された少なくとも1つのアミノ酸配列からなるポリペプチドの使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW097146586A TWI342781B (en) | 2008-12-01 | 2008-12-01 | Blood sugar-modulating polypeptides |
TW097146586 | 2008-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010124827A JP2010124827A (ja) | 2010-06-10 |
JP4772884B2 true JP4772884B2 (ja) | 2011-09-14 |
Family
ID=41723124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009062569A Expired - Fee Related JP4772884B2 (ja) | 2008-12-01 | 2009-03-16 | 血糖値の上昇を抑制するための医薬組成物及び血糖値の上昇を抑制するための薬の製造のためのポリペプチドの使用 |
Country Status (4)
Country | Link |
---|---|
US (2) | US20100137220A1 (ja) |
EP (1) | EP2191837B1 (ja) |
JP (1) | JP4772884B2 (ja) |
TW (1) | TWI342781B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2664622A2 (en) | 2012-05-18 | 2013-11-20 | China Medical University | Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3791862B1 (en) | 2013-09-11 | 2024-05-29 | Eagle Biologics, Inc. | Liquid protein formulations containing viscosity-lowering agents |
TWI580690B (zh) * | 2014-08-25 | 2017-05-01 | The use of multidipins for the manufacture of pharmaceutical compositions for in vivo multipurpose effects | |
US11723946B2 (en) | 2014-08-25 | 2023-08-15 | China Medical University | Methods for regulating transcription of multiple genes and expression of multiple targets |
SG10201902915VA (en) | 2014-10-01 | 2019-04-29 | Eagle Biologics Inc | Polysaccharide and nucleic acid formulations containing viscosity-lowering agents |
CN109452602A (zh) * | 2018-09-29 | 2019-03-12 | 安徽省潜山县全丰农产品开发有限责任公司 | 一种炒制瓜蒌籽的加工工艺 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW283684B (en) | 1995-07-28 | 1996-08-21 | Ing-Bin Jean | Pattern forming method and product for crystal and optics-glass surface |
US6800726B1 (en) * | 1996-11-01 | 2004-10-05 | Pioneer Hi-Bred International, Inc. | Proteins with increased levels of essential amino acids |
ATE403672T1 (de) * | 1997-04-01 | 2008-08-15 | Theracos Inc | Oral aktive fraktion der momordica charantia, ihre aktiven peptide und ihre verwendung bei der behandlung des diabetes |
JP2001278804A (ja) * | 2000-03-30 | 2001-10-10 | Miyazaki Prefecture | 脂質代謝改善剤及びそれを含有する食品 |
JP3628999B2 (ja) * | 2001-12-03 | 2005-03-16 | 株式会社沖縄発酵化学 | 苦瓜茶及びその製造方法 |
CA2532332C (en) * | 2003-07-17 | 2007-10-02 | Sante International, Inc. | Dietary supplement for promoting control of blood-sugar levels and associated pathology in type 2 diabetics |
EA013821B1 (ru) | 2005-05-25 | 2010-08-30 | Кьюрдм, Инк. | Проостровковые пептиды человека, их производные и аналоги и способы их применения |
CN101081244A (zh) * | 2006-05-31 | 2007-12-05 | 浙江日升昌药业有限公司 | 一种植物来源降血糖活性多肽口服生物活性的保存方法 |
-
2008
- 2008-12-01 TW TW097146586A patent/TWI342781B/zh active
-
2009
- 2009-02-25 US US12/392,672 patent/US20100137220A1/en not_active Abandoned
- 2009-03-05 EP EP09154406.4A patent/EP2191837B1/en active Active
- 2009-03-16 JP JP2009062569A patent/JP4772884B2/ja not_active Expired - Fee Related
-
2010
- 2010-11-18 US US12/949,196 patent/US8476229B2/en active Active - Reinstated
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2664622A2 (en) | 2012-05-18 | 2013-11-20 | China Medical University | Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides |
EP2940035A1 (en) | 2012-05-18 | 2015-11-04 | China Medical University | Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides |
Also Published As
Publication number | Publication date |
---|---|
EP2191837A1 (en) | 2010-06-02 |
US20100137220A1 (en) | 2010-06-03 |
JP2010124827A (ja) | 2010-06-10 |
TW201021823A (en) | 2010-06-16 |
US20110124557A1 (en) | 2011-05-26 |
TWI342781B (en) | 2011-06-01 |
EP2191837B1 (en) | 2014-05-07 |
US8476229B2 (en) | 2013-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4772884B2 (ja) | 血糖値の上昇を抑制するための医薬組成物及び血糖値の上昇を抑制するための薬の製造のためのポリペプチドの使用 | |
JP5947872B2 (ja) | ポリペプチド、ポリペプチドをコードする核酸分子、及びポリペプチドを含む医薬組成物 | |
JP4353982B2 (ja) | 糖尿病処置用相乗作用組成物 | |
CN104662038B (zh) | 胰高血糖素类似物 | |
CN113265007B (zh) | 一种治疗代谢疾病的融合蛋白及其制备方法和应用 | |
JP2023554697A (ja) | アニソマイシン誘導体、アニソマイシン及びその誘導体をglp-1r作動薬としての使用方法 | |
WO2001015717A1 (fr) | Agents contenant du ginseng destines a proteger les cellules cerebrales ou les cellules nerveuses | |
CN114075296A (zh) | 一种多功能变体蛋白及其融合蛋白 | |
KR20200116073A (ko) | 폴리펩티드를 함유한 생체 다중효과를 가진 약제학적 조성물 및 그 용도 | |
CN1315964A (zh) | 从苦瓜中获得的蛋白质/多肽-k及其萃取方法 | |
CN114377023B (zh) | 二蒽酮类化合物在制备治疗糖尿病或高脂血症药物中的用途 | |
WO2021208551A1 (zh) | 甲状腺激素及其类似物在制备治疗镰状细胞病中的应用 | |
JP2001139483A (ja) | 薬用人蔘からなる脳細胞または神経細胞保護剤 | |
CN112870211A (zh) | 淫羊藿次苷ⅱ在制备防治急性肝损伤药物中的应用 | |
JP4596793B2 (ja) | 冬虫夏草より見出された新規抗酸化活性物質とその利用 | |
Kravchenko et al. | The study of the hypoglycemic action of extracts from bearberry leaves under experimental insulin resistance in rats | |
Bassett et al. | Bexagliflozin: a comprehensive review of a recently approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus | |
Shi | Explore the Role and Influence of Bex gliflozin (A Type of SGLT-2 Inhibitors) in Type 2 Diabetes | |
Kavadi | Role of Sotagliflozin in Managing Heart Failure in Diabetes | |
CN117603300A (zh) | 具有二肽基肽酶-4抑制活性的小分子肽及其应用 | |
KR20200069225A (ko) | 지속형 엑센딘-4 및 이의 용도 | |
KR20050104098A (ko) | 혈당 강하능을 가지는 물질의 초고속 스크리닝 방법 및세프테졸을 유효성분으로 함유하는 조성물 | |
JP2000327586A (ja) | 糖尿病治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101124 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110208 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110301 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110526 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110614 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110622 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140701 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |